Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
about
A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolatesAntimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins.Antibiotic combinations: should they be tested?Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilliAntimicrobial activity, pharmacokinetics, adverse reactions, and therapeutic indications of cefoperazone.In vitro activity of U-63196E, a new cephalosporin, against clinical bacterial isolates.In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa.Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa.Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis.
P2860
Q34707883-4CE8FE27-986E-4637-A47B-D1DDF884C51DQ35574121-098FFFD1-865C-4815-8C5F-EF19AFB6F833Q35713674-D771876D-16BE-4634-961F-5233BEA74673Q35761805-DDFC607A-C4FD-41AF-BC76-4F9EF190C891Q36632795-4E0944FD-5F7B-4647-81B3-1969DF3A73FBQ39856904-ECA5C488-EB9F-4965-8792-F993B39FCEF5Q39857307-849CC15F-EA1C-4854-A8E7-74722C2830F1Q40114571-C4EE4AA9-DFF6-4E04-AC19-474D2179288AQ42107936-9D1B0D01-8D88-4600-89CB-15D70B0B1BE7Q42108953-157BB2A5-3563-4718-905F-C37C6989BD04Q42928358-6C45E6D1-2D91-478E-92F4-DC3BBB5DF685Q54492446-6F69338B-6931-41B4-BBB3-916AFEF3E4F1
P2860
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Comparative synergistic activi ...... gainst Pseudomonas aeruginosa.
@ast
Comparative synergistic activi ...... gainst Pseudomonas aeruginosa.
@en
type
label
Comparative synergistic activi ...... gainst Pseudomonas aeruginosa.
@ast
Comparative synergistic activi ...... gainst Pseudomonas aeruginosa.
@en
prefLabel
Comparative synergistic activi ...... gainst Pseudomonas aeruginosa.
@ast
Comparative synergistic activi ...... gainst Pseudomonas aeruginosa.
@en
P2860
P356
P1476
Comparative synergistic activi ...... gainst Pseudomonas aeruginosa.
@en
P2860
P304
P356
10.1128/AAC.19.2.332
P407
P577
1981-02-01T00:00:00Z